CONMED CORPORATION Research and Development Expense
CONMED CORPORATION (CNMD) reported Research and Development Expense of $15.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-29
- CONMED CORPORATION research and development expense for the quarter ending 2026-06-30 was $15.50M, a 9.63% increase year-over-year.
- CONMED CORPORATION research and development expense for the quarter ending 2025-12-31 was $14.90M, a 13.08% increase year-over-year.
- CONMED CORPORATION research and development expense for the quarter ending 2025-09-30 was $13.90M, a 2.53% increase year-over-year.
- CONMED CORPORATION research and development expense for the quarter ending 2025-06-30 was $14.14M, a 0.28% increase year-over-year.
- CONMED CORPORATION research and development expense for fiscal 2025 was $55.88M, a 2.68% increase from fiscal 2024.
- CONMED CORPORATION research and development expense for fiscal 2024 was $54.43M, a 3.47% increase from fiscal 2023.
- CONMED CORPORATION research and development expense for fiscal 2023 was $52.60M, a 11.56% increase from fiscal 2022.
- CONMED CORPORATION research and development expense for fiscal 2022 was $47.15M, a 8.23% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.50M 10-Q · filed 2026-07-29 | $31.83M 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $28.80M derived: sum of 2 quarters · filed 2026-02-17 | $42.94M derived: sum of 3 quarters · filed 2026-07-29 | $55.88M 10-K · filed 2026-02-17 |
| 2025-09-30 | $13.90M 10-Q · filed 2025-11-06 | $28.04M derived: sum of 2 quarters · filed 2026-07-29 | $40.98M 10-Q · filed 2025-11-06 | $54.16M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $14.14M 10-Q · filed 2026-07-29 | $27.08M 10-Q · filed 2026-07-29 | $40.26M derived: sum of 3 quarters · filed 2026-07-29 | $53.82M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $12.95M 10-Q · filed 2025-05-01 | $26.12M derived: sum of 2 quarters · filed 2026-02-17 | $39.68M derived: sum of 3 quarters · filed 2026-02-17 | $53.78M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $13.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $26.73M derived: sum of 2 quarters · filed 2026-02-17 | $40.83M derived: sum of 3 quarters · filed 2026-02-17 | $54.43M 10-K · filed 2026-02-17 |
| 2024-09-30 | $13.56M 10-Q · filed 2025-11-06 | $27.66M derived: sum of 2 quarters · filed 2025-11-06 | $41.25M 10-Q · filed 2025-11-06 | $55.28M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $14.10M 10-Q · filed 2025-07-31 | $27.69M 10-Q · filed 2025-07-31 | $41.72M derived: sum of 3 quarters · filed 2026-02-17 | $54.18M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $13.59M 10-Q · filed 2025-05-01 | $27.62M derived: sum of 2 quarters · filed 2026-02-17 | $40.09M derived: sum of 3 quarters · filed 2026-02-17 | $53.66M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $14.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $26.49M derived: sum of 2 quarters · filed 2026-02-17 | $40.06M derived: sum of 3 quarters · filed 2026-02-17 | $52.60M 10-K · filed 2026-02-17 |
| 2023-09-30 | $12.46M 10-Q · filed 2024-10-31 | $26.04M derived: sum of 2 quarters · filed 2024-10-31 | $38.57M 10-Q · filed 2024-10-31 | $50.80M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $13.57M 10-Q · filed 2024-08-01 | $26.11M 10-Q · filed 2024-08-01 | $38.33M derived: sum of 3 quarters · filed 2025-02-18 | $51.10M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $12.54M 10-Q · filed 2024-04-25 | $24.76M derived: sum of 2 quarters · filed 2025-02-18 | $37.53M derived: sum of 3 quarters · filed 2025-02-18 | $49.02M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $12.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $24.99M derived: sum of 2 quarters · filed 2025-02-18 | $36.48M derived: sum of 3 quarters · filed 2025-02-18 | $47.15M 10-K · filed 2025-02-18 |
| 2022-09-30 | $12.77M 10-Q · filed 2023-10-26 | $24.26M derived: sum of 2 quarters · filed 2023-10-26 | $34.93M 10-Q · filed 2023-10-26 | $46.29M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $11.49M 10-Q · filed 2023-07-27 | $22.16M 10-Q · filed 2023-07-27 | $33.53M derived: sum of 3 quarters · filed 2024-02-28 | $44.39M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $10.67M 10-Q · filed 2023-04-27 | $22.03M derived: sum of 2 quarters · filed 2024-02-28 | $32.89M derived: sum of 3 quarters · filed 2024-02-28 | $44.21M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $22.22M derived: sum of 2 quarters · filed 2024-02-28 | $33.54M derived: sum of 3 quarters · filed 2024-02-28 | $43.56M 10-K · filed 2024-02-28 |
| 2021-09-30 | $10.86M 10-Q · filed 2022-10-27 | $22.18M derived: sum of 2 quarters · filed 2022-10-27 | $32.20M 10-Q · filed 2022-10-27 | $43.92M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $11.32M 10-Q · filed 2022-07-28 | $21.34M 10-Q · filed 2022-07-28 | $33.06M derived: sum of 3 quarters · filed 2023-02-21 | $43.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $10.03M 10-Q · filed 2022-05-05 | $21.74M derived: sum of 2 quarters · filed 2023-02-21 | $31.68M derived: sum of 3 quarters · filed 2023-02-21 | $40.38M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $11.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $21.65M derived: sum of 2 quarters · filed 2023-02-21 | $30.35M derived: sum of 3 quarters · filed 2023-02-21 | $40.47M 10-K · filed 2023-02-21 |
| 2020-09-30 | $9.94M 10-Q · filed 2021-10-28 | $18.64M derived: sum of 2 quarters · filed 2021-10-28 | $28.76M 10-Q · filed 2021-10-28 | $40.85M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $8.70M 10-Q · filed 2021-07-29 | $18.82M 10-Q · filed 2021-07-29 | $30.91M derived: sum of 3 quarters · filed 2022-02-22 | $41.90M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $10.12M 10-Q · filed 2021-04-29 | $22.21M derived: sum of 2 quarters · filed 2022-02-22 | $33.20M derived: sum of 3 quarters · filed 2022-02-22 | $45.01M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $12.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $23.08M derived: sum of 2 quarters · filed 2022-02-22 | $34.88M derived: sum of 3 quarters · filed 2022-02-22 | $45.46M 10-K · filed 2022-02-22 |
| 2019-09-30 | $10.98M 10-Q · filed 2020-10-29 | $22.79M derived: sum of 2 quarters · filed 2020-10-29 | $33.37M 10-Q · filed 2020-10-29 | $43.74M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $11.81M 10-Q · filed 2020-07-30 | $22.38M 10-Q · filed 2020-07-30 | $32.75M derived: sum of 3 quarters · filed 2021-02-22 | $46.87M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $10.57M 10-Q · filed 2020-04-30 | $20.95M derived: sum of 2 quarters · filed 2021-02-22 | $35.07M derived: sum of 3 quarters · filed 2021-02-22 | $45.05M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $10.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $24.49M derived: sum of 2 quarters · filed 2021-02-22 | $34.48M derived: sum of 3 quarters · filed 2021-02-22 | $42.19M 10-K · filed 2021-02-22 |
| 2018-09-30 | $14.12M 10-Q · filed 2019-10-31 | $24.11M derived: sum of 2 quarters · filed 2019-10-31 | $31.82M 10-Q · filed 2019-10-31 | $40.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $9.98M 10-Q · filed 2019-08-01 | $17.70M 10-Q · filed 2019-08-01 | $26.07M derived: sum of 3 quarters · filed 2020-02-24 | $34.34M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $7.71M 10-Q · filed 2019-04-26 | $16.09M derived: sum of 2 quarters · filed 2020-02-24 | $24.36M derived: sum of 3 quarters · filed 2020-02-24 | $32.40M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $8.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $16.65M derived: sum of 2 quarters · filed 2020-02-24 | $24.69M derived: sum of 3 quarters · filed 2020-02-24 | $32.31M 10-K · filed 2020-02-24 |
| 2017-09-30 | $8.27M 10-Q · filed 2018-11-02 | $16.31M derived: sum of 2 quarters · filed 2018-11-02 | $23.93M 10-Q · filed 2018-11-02 | $31.56M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $8.04M 10-Q · filed 2018-08-02 | $15.66M 10-Q · filed 2018-08-02 | $23.29M derived: sum of 3 quarters · filed 2019-02-25 | $31.65M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $7.62M 10-Q · filed 2018-04-26 | $15.25M derived: sum of 2 quarters · filed 2019-02-25 | $23.61M derived: sum of 3 quarters · filed 2019-02-25 | $31.61M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $15.99M derived: sum of 2 quarters · filed 2019-02-25 | $24.00M derived: sum of 3 quarters · filed 2019-02-25 | $32.25M 10-K · filed 2019-02-25 |
| 2016-09-30 | $8.35M 10-Q · filed 2017-11-02 | $16.36M derived: sum of 2 quarters · filed 2017-11-02 | $24.62M 10-Q · filed 2017-11-02 | $31.36M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $8.01M 10-Q · filed 2017-07-27 | $16.27M 10-Q · filed 2017-07-27 | $23.01M derived: sum of 3 quarters · filed 2018-02-26 | $29.66M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $8.26M 10-Q · filed 2017-04-27 | $15.00M derived: sum of 2 quarters · filed 2018-02-26 | $21.65M derived: sum of 3 quarters · filed 2018-02-26 | $29.15M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $13.39M derived: sum of 2 quarters · filed 2018-02-26 | $20.89M derived: sum of 3 quarters · filed 2018-02-26 | $27.44M 10-K · filed 2018-02-26 |
| 2015-09-30 | $6.65M 10-Q · filed 2016-10-28 | $14.15M derived: sum of 2 quarters · filed 2016-10-28 | $20.70M 10-Q · filed 2016-10-28 | $27.80M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $7.50M 10-Q · filed 2016-07-28 | $14.04M 10-Q · filed 2016-07-28 | $21.15M derived: sum of 3 quarters · filed 2017-02-27 | $28.06M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $6.54M 10-Q · filed 2016-05-02 | $13.65M derived: sum of 2 quarters · filed 2017-02-27 | $20.56M derived: sum of 3 quarters · filed 2017-02-27 | $27.41M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $14.02M derived: sum of 2 quarters · filed 2017-02-27 | $20.87M derived: sum of 3 quarters · filed 2017-02-27 | $27.78M 10-K · filed 2017-02-27 |
| 2014-09-30 | $6.91M 10-Q · filed 2015-10-23 | $13.76M derived: sum of 2 quarters · filed 2015-10-23 | $20.67M 10-Q · filed 2015-10-23 | $27.11M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $6.85M 10-Q · filed 2015-07-27 | $13.76M 10-Q · filed 2015-07-27 | $20.20M derived: sum of 3 quarters · filed 2016-02-23 | $27.31M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $6.91M 10-Q · filed 2015-04-24 | $13.35M derived: sum of 2 quarters · filed 2016-02-23 | $20.46M derived: sum of 3 quarters · filed 2016-02-23 | $27.05M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $13.55M derived: sum of 2 quarters · filed 2016-02-23 | $20.14M derived: sum of 3 quarters · filed 2016-02-23 | $25.83M 10-K · filed 2016-02-23 |
| 2013-09-30 | $7.11M 10-Q · filed 2014-10-24 | $13.70M derived: sum of 2 quarters · filed 2014-10-24 | $19.39M 10-Q · filed 2014-10-24 | $26.24M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $6.59M 10-Q · filed 2014-07-25 | $12.29M 10-Q · filed 2014-07-25 | $19.14M derived: sum of 3 quarters · filed 2015-02-23 | $26.21M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $5.69M 10-Q · filed 2014-04-25 | $12.54M derived: sum of 2 quarters · filed 2015-02-23 | $19.62M derived: sum of 3 quarters · filed 2015-02-23 | $26.81M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $13.93M derived: sum of 2 quarters · filed 2015-02-23 | $21.12M derived: sum of 3 quarters · filed 2015-02-23 | $28.21M 10-K · filed 2015-02-23 |
| 2012-09-30 | $7.08M 10-Q · filed 2013-10-28 | $14.27M derived: sum of 2 quarters · filed 2013-10-28 | $21.36M 10-Q · filed 2013-10-28 | $28.52M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $7.19M 10-Q · filed 2013-07-29 | $14.29M 10-Q · filed 2013-07-29 | $21.44M derived: sum of 3 quarters · filed 2014-02-24 | $28.46M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $7.09M 10-Q · filed 2013-04-29 | $14.25M derived: sum of 2 quarters · filed 2014-02-24 | $21.27M derived: sum of 3 quarters · filed 2014-02-24 | $28.07M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $7.15M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $14.17M derived: sum of 2 quarters · filed 2014-02-24 | $20.97M derived: sum of 3 quarters · filed 2014-02-24 | $28.65M 10-K · filed 2014-02-24 |
| 2011-09-30 | $7.02M 10-Q · filed 2012-10-29 | $13.82M derived: sum of 2 quarters · filed 2012-10-29 | $21.50M 10-Q · filed 2012-10-29 | $29.63M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-06-30 | $6.80M 10-Q · filed 2012-07-30 | $14.48M 10-Q · filed 2012-07-30 | $22.61M derived: sum of 3 quarters · filed 2013-02-25 | $30.01M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-03-31 | $7.68M 10-Q · filed 2012-05-01 | $15.81M derived: sum of 2 quarters · filed 2013-02-25 | $23.21M derived: sum of 3 quarters · filed 2013-02-25 | $29.65M derived: sum of 4 quarters · filed 2013-02-25 |
| 2010-12-31 | $8.13M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $15.53M derived: sum of 2 quarters · filed 2013-02-25 | $21.97M derived: sum of 3 quarters · filed 2013-02-25 | $29.65M 10-K · filed 2013-02-25 |
| 2010-09-30 | $7.40M 10-Q · filed 2011-11-01 | $13.84M derived: sum of 2 quarters · filed 2011-11-01 | $21.52M 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $6.44M 10-Q · filed 2011-08-09 | $14.12M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $31.84M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |